About Taiho
Our Business
Our Science
January 18, 2021
Taiho Pharmaceutical Launches Its First Food with Function Claims Product to Counter Cold Hands Among Women
January 15, 2021
Taiho Pharmaceutical Announces Establishment of a New Company as a Clinical Development and Commercial Base in Switzerland
January 13, 2021
Taiho and Astex Extend Strategic Oncology Collaboration with MSD Granting Exclusive License to SHP2 Program
January 12, 2021
Taiho Pharmaceutical Fully Adopts Carbon-Neutral Electricity at Saitama Site（PDF：127.2 KB）
January 05, 2021
Taiho Pharmaceutical Begins Phase III Clinical Trial with Therapeutic Drug for Duchenne Muscular Dystrophy (TAS-205) in Japan
